<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002204'>Pulmonary embolism</z:hpo> is an unusual complication of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="1" pm="."><plain>Our aim study is to analyse epidemiological, physiopathological and evolutive aspects of this condition </plain></SENT>
<SENT sid="2" pm="."><plain>Among 153 patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease according to the criteria of the International Study Group for <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, seven (5 men and 2 women mean aged at 26.6 +/- 6 years) were diagnosed as having <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This was inaugural in 3 cases; for 2 females, <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">complicated pregnancy</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Cardiac <z:mp ids='MP_0005048'>thrombosis</z:mp> was presented in 2 cases and pulmonary <z:hpo ids='HP_0002617'>aneurysm</z:hpo> in 2 patients </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0034074" disease_type="Disease or Syndrome" abbrv="">Pulmonary infarction</z:e> has been noted in 4 cases </plain></SENT>
<SENT sid="6" pm="."><plain>Protein C, protein S and antithrombin III levels were <z:mpath ids='MPATH_458'>normal</z:mpath> in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="7" pm="."><plain>One patient was positive for IgG anticardiolipin antibody </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> has been noted (17 to 30 micromol/) in 5 cases </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> our patients were treated successfully by anticoagulation therapy combined with high dose <z:chebi fb="0" ids="8382">prednisone</z:chebi>, <z:chebi fb="0" ids="23359">colchicine</z:chebi> and intravenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> in 6 patients </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0002204'>Pulmonary embolism</z:hpo> is one of the severe and worst prognostic manifestations of the disease </plain></SENT>
<SENT sid="11" pm="."><plain>Furthermore, the <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> may play an important role in the pathogenesis of such complication </plain></SENT>
<SENT sid="12" pm="."><plain>Immunomodulation therapy associated to <z:chebi fb="3" ids="37445">folate</z:chebi> may be beneficial to attenuate this <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> especially, when introduced in the early stages </plain></SENT>
</text></document>